Get the Stockscreener App
4.20
10.53%
0.40
After Hours:
4.07
-0.13
-3.10%
Universe Pharmaceuticals Inc stock is traded at $4.20, with a volume of 264.45K.
It is up +10.53% in the last 24 hours and down -6.67% over the past month.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
See More
Previous Close:
$3.80
Open:
$4
24h Volume:
264.45K
Relative Volume:
0.67
Market Cap:
$1.58M
Revenue:
$32.31M
Net Income/Loss:
$-6.16M
P/E Ratio:
-2.4706
EPS:
-1.7
Net Cash Flow:
$1.08M
1W Performance:
+17.98%
1M Performance:
-6.67%
6M Performance:
-97.93%
1Y Performance:
-99.70%
1-Day Range:
$3.68
$4.30
1-Week Range:
$3.06
$5.47
52-Week Range:
$2.51
$2,592.00
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Compare UPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UPC
Universe Pharmaceuticals Inc
|
4.20 | 1.58M | 32.31M | -6.16M | 1.08M | -1.70 |
|
ZTS
Zoetis Inc
|
153.47 | 65.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 46.99B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.18 | 45.96B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.87 | 17.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
291.38 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Universe Pharmaceuticals Inc Stock (UPC) Latest News
Universe Pharmaceuticals INC (UPC) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Diversicare Healthcare Services (OTCMKTS:DVCR) Trading Up 1% – Still a Buy? - Defense World
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Universe Pharmaceuticals stock plunges to 52-week low of $3.20 - Investing.com
Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
Pre-market Movers: TNON, POAI, MURA, BSGM... - RTTNews
Upcoming Stock Splits This Week (March 24 to March 28) – Stay Invested - The Globe and Mail
Universe Pharmaceuticals stock plunges to 52-week low of $0.08 By Investing.com - Investing.com Australia
Universe Pharmaceuticals stock plunges to 52-week low of $0.08 - Investing.com
Universe Pharmaceuticals Announces Share Consolidation - TipRanks
Universe Pharmaceuticals Plans To Effect Share ConsolidationQuick Facts - Nasdaq
Universe Pharmaceuticals INC Announces Share Consolidation Effective March 24, 2025 - Nasdaq
NewtekOne, Inc. Closes Private Offering of Senior Unsecured Notes - The Manila Times
Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewswire
Major Shake-up: Universe Pharmaceuticals Announces 40:1 Share ConsolidationWhat It Means For Investors - StockTitan
Universe Pharmaceuticals stock plunges to 52-week low of $0.1 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals stock plunges to 52-week low of $0.1 - Investing.com India
Universe Pharmaceuticals (NYSE:UPC) Trading Down 4.3% – What’s Next? - Defense World
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
Universe Pharmaceuticals Approves Share Consolidation at Extraordinary Meeting - TipRanks
UPC’s price-to-book ratio: An indicator of the company’s performance - US Post News
Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum - TipRanks
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 - Investing.com India
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report - MSN
Universe Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com Australia
Universe Pharmaceuticals faces potential Nasdaq delisting - Investing.com India
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - The Manila Times
Universe Pharmaceuticals Faces Nasdaq Delisting Risk Due to Delayed Annual Report - TipRanks
Universe Pharmaceuticals INC Faces Potential Delisting from Nasdaq Due to Delinquent Annual Report Filing - Nasdaq
Will Universe Pharmaceuticals Survive Nasdaq's Latest Delisting Threat? - StockTitan
Looking Into Universe Pharmaceuticals's Recent Short Interest - Benzinga
Promising Chinese Stocks Worth Watching – February 21st - Defense World
Dow Tumbles Over 700 Points; US Services PMI Falls In February - Benzinga
Stock market today: Nuburu surged by 81.61% while Aspire Biopharma Holdings plummented by 44.32% in early trading - Business Upturn
Why Five9 Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Universe Pharmaceuticals Adjourns Shareholder Meeting Indefinitely - TipRanks
Universe Pharmaceuticals Adjourns Extraordinary General Meeting Due to Lack of Quorum - TipRanks
Universe Pharmaceuticals Inc Stock (UPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
1.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):